Dare Bioscience, Inc. Common Stock
Symbol: DARE (NASDAQ)
2.16
▲ (2.81%) 0.059
Company Description:
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Key Stats
- Today's Open: $2.11
- Today's High: $2.169
- Today's Low: $2.115
- Today's Volume: 90.91K
- Yesterday Close: $2.1
- Yesterday High: $2.14
- Yesterday Low: $2.08
- Yesterday Volume: 94.39K
- Last Min Volume: 2
- Last Min High: $2.159
- Last Min Low: $2.143
- Last Min VWAP: $2.143
Company Profile
- Name: Dare Bioscience, Inc. Common Stock
- Website: https://www.darebioscience.com
- Listed Date: 2014-04-10
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001401914
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $28.31M
- Round Lot: 100
- Outstanding Shares: 13.48M
- Asset Type: CS
RECENT FILINGS FOR DARE
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-04 | 4 | View |
| 2025-09-02 | 8-K | View |
| 2025-08-14 | S-8 | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-07-25 | 8-K | View |
| 2025-07-21 | 8-K | View |
| 2025-07-14 | 8-K | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-09 | 8-K | View |
| 2025-06-25 | 8-K | View |
| 2025-06-12 | DEFA14A | View |
| 2025-06-09 | 8-K | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-13 | 8-K | View |
| 2025-04-24 | ARS | View |
Latest News on DARE